Nandini Mukhopadhyay Meyersohn, M.D.
This page shows the publications co-authored by Nandini Meyersohn and Borek Foldyna.
Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial. Eur Radiol. 2021 Jan 26.
Epicardial Adipose Tissue in Patients With Stable Chest Pain: Insights From the PROMISE Trial. JACC Cardiovasc Imaging. 2020 10; 13(10):2273-2275.
Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. Clin Gastroenterol Hepatol. 2020 Jul 21.
Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging. 2019 May 01; 20(5):574-581.
Risk Stratification With the Use of Coronary Computed Tomographic Angiography in Patients With Nonobstructive Coronary Artery Disease. JACC Cardiovasc Imaging. 2021 Apr 08.
Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain. JACC Cardiovasc Imaging. 2020 05; 13(5):1282-1284.
Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE. JACC Cardiovasc Imaging. 2020 07; 13(7):1534-1545.
Randomized Trial Comparing Transdermal With Sublingual Nitroglycerin Administration for Coronary Vasodilation in CTA. JACC Cardiovasc Imaging. 2019 09; 12(9):1890-1893.
Central Core Laboratory versus Site Interpretation of Coronary CT Angiography: Agreement and Association with Cardiovascular Events in the PROMISE Trial. Radiology. 2018 04; 287(1):87-95.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.